Saw Instruments and Acobio KK Sign Exclusive Agreement to Distribute sam® Biosensors in Japan

Saw Instruments, a developer of innovative biosensor technology for life sciences research, and Acobio KK, have signed an exclusive agreement to allow Acobio KK to distribute Saw’s innovative sam^® range of acoustic biosensors in Japan. sam^® systems provide a step-change in biosensor technology and applications, offering new capabilities for studying real-time kinetics on the surface of live mammalian cells. Acobio KK, which is owned by the Altair Corporation, was established in December 2011 to distribute innovative life science products in Japan.

Mr Eiji Takagi, President of Acobio KK, said: “Using our extensive experience in the pharmaceutical and biotechnology industries, Acobio’s mission is to make innovative life science technology and products from across the globe available for use by academia and industry in Japan. We are particularly pleased to have signed this agreement with Saw Instruments, as the company’s novel range of sam^® biosensors open up new avenues for studying molecular interactions on the surface of mammalian cells.” Unlike other cell-based detection platforms, sam^® acoustic biosensors do not require any fluorescent labelling, are real-time rather than steady-state, and can use unfixed cells adhered to the sensor surface or in suspension, all while providing rapid analysis in the order of only a few
minutes.

Dr Markus Perpeet, Managing Director of Saw Instruments, commented: “We are very pleased that our innovative sam® systems, which have already proven highly popular with researchers in Europe and the US, will now be available in Japan.